Navigation Links
Neurotechnology Industry Reports Record Global Growth of $130.5 Billion in 2007
Date:5/8/2008

NeuroInsights unveils expanded fourth edition of comprehensive market analysis and strategic investment report at Neurotech Industry Conference

SAN FRANCISCO and BOSTON, May 8 /PRNewswire/ -- NeuroInsights, the neurotech market authority, announced today the release of the organization's fourth annual comprehensive investment guide and market analysis of the global neurological disease and psychiatric illness markets. Unveiled during the annual Neurotech Industry Investing and Partnering Conference in Boston, this 400-page report enables investors, companies and governments to assess opportunities, calculate risks and understand the dynamics of this continually changing market.

The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System tracks market movements that help guide strategic business development and investment decisions in neurotech. This year's report provides an in-depth look at more than 16 brain and nervous system disorders and treatments in development at over 500 public and private companies, including: Alzheimer's disease, addiction, ADHD, anxiety, depression, epilepsy, migraine, mild cognitive impairment, multiple sclerosis, obesity, pain, Parkinson's disease, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, stroke and traumatic brain injury. Corporate financing, market activity, growth drivers and global industry conditions that make up the obstacles and opportunities facing the industry are fully assessed with detailed insights.

Specific findings from the Neurotechnology Industry 2008 Report show that in 2007:

-- Brain-related illnesses represent the largest unmet medical market with

two billion people worldwide

-- Venture capital investment in neurotechnology reached an all-time high

at $1.77 billion

-- More than 250 investors participated in neurotech financings

-- Global neurotech industry revenues rose 8.3% to $130.5 billion

-- Neuropharmaceuticals recorded revenues of $109 billion and 8% annual

growth

-- Neurodevices recorded revenues of $5.5 billion and 22% annual growth

-- Neurodiagnostics recorded revenues of $16 billion and 6% annual growth

"The neurotechnology industry made substantial gains in 2007, which has continued into 2008," said Casey Lynch, Managing Director of NeuroInsights. "Commercial neuroscience represents one of the fastest-growing and critically needed sectors of the healthcare industry. In 2007, this was underscored in the launch of several important industry initiatives, including the creation of the NASDAQ NeuroInsights Neurotech Index in September."

Specific milestones from the report were presented during NeuroInsights' annual Neurotech Industry Investing and Partnering Conference, hosted in partnership with the Neurotechnology Industry Organization. This conference, being held at the Westin Copley Place in Boston today and tomorrow, is the premier global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.

The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System is now available for purchase in book or digital format at http://www.neuroinsights.com/marketreports/marketreport2008.html

About NeuroInsights

NeuroInsights is the world's leading neurotechnology research and advisory firm. As the neurotechnology market authority, NeuroInsights helps investors, industry and society understand and profit from the rapid growth in drugs, devices and diagnostics for the brain and nervous system. NeuroInsights provides market reports, investment information, industry events and strategic advisory services to venture funds, startups, corporations, governments and financial institutions. For more information, visit http://www.neuroinsights.com.

Contact:

Casey Lynch

NeuroInsights

(415) 229-3225

casey@neuroinsights.com


'/>"/>
SOURCE NeuroInsights
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007
2. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
3. Facet Solutions, Inc. Appoints Industry Veteran to Board of Directors
4. Anthem Blue Cross and Blue Shield in Connecticut Introduces Industrys First Electronic Tool to Help Members Search In-Network Doctors and Hospitals; Transparency Tool to Enable Searches Via Web-Enabled Cell Phones or Hand-Held Devices
5. Anthem Blue Cross and Blue Shield Introduces Industrys Most Comprehensive Transparency Initiative to Wisconsin
6. Pharma Industry Group Favors Obama as Next President
7. Key Industry and Government Officials to Address Medical Technology Executives
8. China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention
9. The National Association of Specialty Health Organizations to Recognize Excellence in Technology Education With Industry Award
10. Siemens Healthcare Executives Recognized With New Industry Leadership Positions
11. Entertainment Industry Foundation Revlon Run/Walk for Women Celebrates 11 Years in New York City on Saturday, May 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... Berkeley, and other leading institutions in announcing the launch of the Leadership ... the way animals are raised for food. , Founding members of the Leadership ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... -- AVACEN Medical , Inc. (AVACEN) announced that Frost ... Product Innovation Award for Its fibromyalgia pain management device. ... device market research by Frost & Sullivan,s industry experts. ... relief product, the AVACEN 100, offers a safe and effective ... ...
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology: